Hong Kong, China

Fu-Yao Zhang

This inventor holds 2 USPTO granted patents. Top assignee: The Hong Kong Polytechnic University. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fu-Yao Zhang: Innovator in Chiral Aminophosphines

Introduction

Fu-Yao Zhang is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of chemistry, particularly in the development of chiral aminophosphines. With a total of 2 patents, his work has garnered attention for its innovative approaches and practical applications.

Latest Patents

Zhang's latest patents focus on chiral aminophosphines, specifically the compounds (R)- and (S)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diamine and (R)- and (S)-2,2'-bis(diarylphospinoamino)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl. His inventions detail processes for the preparation of these compounds, including the use of Adam's catalyst and n-butyllithium. Additionally, he has developed rhodium complexes that serve as effective catalysts for the asymmetric hydrogenation of prochiral substrates, achieving high chemical yields and enantiomeric excess.

Career Highlights

Fu-Yao Zhang is affiliated with The Hong Kong Polytechnic University, where he continues to advance his research in chemistry. His work has not only contributed to academic knowledge but also has practical implications in various chemical processes.

Collaborations

Zhang collaborates with fellow researcher Albert Sun-Chi Chan, enhancing the scope and impact of their work in the field of chemistry.

Conclusion

Fu-Yao Zhang's innovative contributions to chiral aminophosphines exemplify the importance of research in advancing chemical applications. His patents reflect a commitment to excellence and innovation in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…